StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Chondroitin, 4-(Hydrogensulfat)

Chondroitin Sulfate

HCID 24766
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
24967-93-9
Standard-SMILES
CC(=O)N[C@@H]1[C@@H](O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H](OS(=O)(=O)O)O[C@H]1O
InChIKey
KXKPYJOVDUMHGS-OSRGNVMNSA-N
Summenformel
C13H21NO15S
Durchschnittliche Molmasse
463,37 g/mol
Monoisotopische Masse
463,06319014

Überblick

Chondroitin sulfate is a glycosaminoglycan considered as a symptomatic slow-acting drug for osteoarthritis (SYSADOA). The SYSADOA status suggested a pain relief and increased joint mobility after a relative long regular administration, as well as a long-lasting effect after the end of the treatment. Chondroitin sulfate is composed of alternating 1,3-N-acetyl-β-d-galactosamine and 1,4-β-d-glucuronic acid units which bear 4-O- and/or 6-O-sulfations at the N-acetylgalactosamine units disposed of in specific patterns. Depending on the predominating disaccharide unit, it will present different biological activities. Chondroitin sulfate is sold as an OTC dietary supplement in North America and it is a prescription drug under the EMA in Europe.

Namen und Bezeichner

Bevorzugter Name
Chondroitin Sulfate
IUPAC
(2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-sulfooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
Lokaler Name
Chondroitin, 4-(Hydrogensulfat)
Englischer Name
Chondroitin 4-sulfate
Summenformel
(C14H19NO14SNa2)n
Molmasse
499.38

Namen und Synonyme

Chondroitin sulfate9007-28-7Chondroitin, hydrogen sulfateCHEBI:37397(2S,3S,4S,5R,6R)-6-{[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxy)oxan-4-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid(2S,3S,4S,5R,6R)-6-(((2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxy)oxan-4-yl)oxy)-3,4,5-trihydroxyoxane-2-carboxylic acidRefChem:7109DTXSID8031021Sodium chondroitin sulfate39455-18-0Chondroitine sulfateChondroitin 4-sulfate sodium salt
Weitere Namen anzeigen
CHONDROITIN-4-SULFATECHONDROITIN SULFATE AturkadonChodroitin SulfatechondroitinasulfateChondroitinSulphateAchondroitinsulfatetypeaCSAChondroitin-4-sulfate
(2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-sulfooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acidMFCD00146419CondrosulfChondroitinsulfate CC13H21NO15SChondroitin 4 and 6 sulfateChondronStructum

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
-4,8
Polarare Oberfläche (TPSA)
267 Ų
H-Brücken-Donoren
8
H-Brücken-Akzeptoren
15
Frei drehbare Bindungen
6
Schwere Atome
30
Formalladung
0
Komplexität
739

Experimentelle und physikochemische Eigenschaften

CosmeticsAntistatic; Hair conditioning
SolubilitySoluble
Melting Point190-194ºC
Dissociation Constants1.5-2

Physikochemische Eigenschaften

storage temp.
2 · 2-8°C
Löslichkeit
2 O: · H2O: 0.1 g/mL, slightly hazy, faintly yellow

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 5 Einträge

This chemical does not meet GHS hazard criteria for 63.6% (7 of 11) of all reports.

Danger

H317 (36.4%): May cause an allergic skin reaction [Warning Sensitization, Skin]

P233, P260, P261, P271, P272, P280, P284, P302+P352, P304+P340, P317, P321, P333+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 11 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory Information · 4 Einträge

Chemical: Chondroitin, hydrogen sulfate

XU - indicates a substance exempt from reporting under the Chemical Data Reporting Rule, (40 CFR 711).

Chondroitin, hydrogen sulfate, sodium salt: Does not have an individual approval but may be used under an appropriate group standard

Chondroitin hydrogen sulfate: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Chondroitin, hydrogen sulfate: Environment tier I assessment
Hazard Classes and CategoriesSkin Sens. 1 (36.4%)

Sicherheitsdaten

F
3-10
wgk
3
Toxizität
mouse,LD,oral,> 15gm/kg (15000mg/kg),Zhonghua Yixue Zazhi. Chinese Medical Journal. Vol. 58, Pg. 739, 1978.

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

M - Musculo-skeletal system

QM - Musculo-skeletal system

Protein BindingChondroitin sulfate protein binding reports have shown a very low percentage of protein binding of only 0.23% of the total protein.
Pharmacodynamics · 1 Eintrag

In clinical trials, chondroitin sulfate has been reported a significant pain relief. Some reports have shown no slow in joint damage. The effects of chondroitin sulfate have been very controversial. One of the characteristics of chondroitin is a slow onset of action with a maximal effect attained after several months. Chondroitin sulfate has been reported to have anti-inflammatory properties by reducing the synovitis and prevent proinflammatory cytokine up-regulation in arthritis models. It is also registered an anabolic effect of chondroitin sulfate in which it induces the synthesis of hyaluronate in synovial cells, it increases type II collagen and proteoglycan synthesis.

Mechanism of Action · 1 Eintrag

Chondroitin sulfate functions as a major component of the intricate extracellular matrix. It is proposed that chondroitin sulfate supply can provide new building blocks for the synthesis of new matrix components. The anti-inflammatory effect of chondroitin sulfate is thought to be caused by the inhibition of the synthesis of inflammatory intermediates such as the inhibition of nitric oxide synthase, COX-2, microsomal prostaglandin synthase 1 and prostaglandin E2. It is reported also an inhibitory activity in the toll-like receptor 4 which will later inhibit inflammatory cytokines, NFkB and MyD88. This activity suggests a modulation of the MAP kinase pathway. On the other hand, some reports have pointed out an induction on the PKC/PI3K/Akt pathway in neuroblastoma. The anabolic effect of chondroitin sulfate is suggested to be caused by the inhibition of metalloproteinases such as MMP-1, -3 and -13 as well as ADAMTS-4 and -5.

Biological Half-Life · 1 Eintrag

The approximate half-life of chondroitin sulfate and its derivative metabolites is 15 hours. After intramuscular administration of chondroitin sulfate in humans, the elimination half-life of the chondroitin sulfate was of 275 min. When administered orally, the elimination half-life was presented at 310 min.

Zugehörige Reaktionen

5
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 1003920
HRID 1003920als Edukt
Reaktionsgleichung von HRID 1095260
HRID 1095260als Edukt
Reaktionsgleichung von HRID 1714702
HRID 1714702als Edukt
Reaktionsgleichung von HRID 1816867
HRID 1816867als Edukt
Reaktionsgleichung von HRID 2239213
HRID 2239213als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung

Datenbank-Bezeichner

CAS
24967-93-9、25322-46-7、39455-18-0、9007-28-7、9082-07-9
PubChem CID
24766
DTXSID
DTXSID601017238
ChEMBL
CHEMBL2303614、CHEMBL5266347
EC Number
232-696-9
Metabolism/Metabolites · 1 Eintrag

Chondroitin sulfate is not metabolized by cytochrome P450. Reports have indicated the presence in plasma of mono-, oligo- and polysaccharides with a molecular weight of less of 5 kDa which are derived from the partial digestion of exogenous chondroitin sulfate. The reported degradation of chondroitin sulfate seems to be very complex and led by the formation of smaller digestion derivatives of the original form.

Absorption, Distribution and Excretion · 3 Einträge

Chondroitin sulfate is absorbed from the gastrointestinal tract. The absorbed portion reaches a ratio of 10% as unchanged chondroitin sulfate and 90% as depolymerized low-molecular-weight derivatives. This absorption depends on the sulfation status. The bioavailability of chondroitin sulfate ranges from 10-20% following oral administration. Reports have shown a consistent accumulation of the compound in joint tissue. The steady-state is attained after 3-4 days and it takes around 3-6 months to obtain the maximal effect. After intramuscular administration of chondroitin sulfate, the peak plasma level of 3.8 mcg/ml was reached after 90 min. When given orally, the peak plasma concentration of 4.6 mcg/ml was reached after 240 min.

Chondroitin sulfate is excreted in the urine as intact polymers and as partial degradation products. After intramuscular administration, about 37% of the administered dose is excreted by urine during the first 24 hours as high- and low-molecular-weight derivatives.

After intramuscular administration of chondroitin sulfate, the apparent volume of distribution was 0.40 ml/g. When administered orally, the apparent volume of distribution changed to 0.44ml/g.

Verwendung und Herstellung

Household ProductsInformation on 4 consumer products that contain Sodium chondroitin sulfate in the following categories is provided:
Use ClassificationCosmetics -> Antistatic; Hair conditioning
General Manufacturing InformationChondroitin, hydrogen sulfate: ACTIVE
Anwendungen · 2 Einträge

BeschreibungChondroitin 4-sulfate is a natural polymer of a disaccharide consisting of glucuronic acid and N-acetyl glucosamine which is sulfated either in the 4 or 6 position. It is a glycosaminoglycan considered as a symptomatic slow-acting drug for osteoarthritis (SYSADOA).

Verwendensodium chondroitin sulfate is described as a skin-conditioning agent, with possible anti-inflammatory properties. It can be found in such products as moisturizers and night skin care preparations. It is a derivative of natural mucopolysaccharides. Chondroitin 4-sulfate is an important structural component of cartilage and has been used as a dietary supplement to treat symptoms of joint discomfort.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Strong acid styrene cation exchange resinΑ-proteinPankreatin

Ergänzende Hinweise

DefinitionChEBI: Chondroitin 4'-sulfate is a chondroitin sulfate in which the site of sulfation is carbon 4 of the N-acetylgalactosamine (GalNAc) sugar. It has a role as a mouse metabolite. It is a conjugate acid of a chondroitin 4'-sulfate anion.